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Abstract
Background: Research indicates schizophrenia is a cause of burden for patients and caregivers. This study
examined health-related quality of life (HRQoL) and comorbidities experienced by informal schizophrenia caregivers
compared with non-caregivers and caregivers of adults with other conditions (e.g., Alzheimer’s disease, cancer, and
stroke).
Methods: Data were obtained from the 5EU (France, Germany, Italy, Spain, UK) National Health and Wellness
Survey, an online questionnaire that is representative of the total 5EU adult (18+ years) population. Respondents
provided information on HRQoL (SF-36v2: mental and physical component summary (MCS, PCS) and SF-6D (health
utility) scores), items from the Caregiver Reaction Assessment (strongly disagree to strongly agree) and comorbidities
(sleep difficulties, insomnia, pain, headaches, heartburn, anxiety, depression) experienced in the past 12 months.
Schizophrenia caregivers (n = 398) were matched to non-caregivers (n = 158,989) and caregivers of other conditions
(n = 14,341) on baseline characteristics via propensity scores. Chi-square tests and ANOVAs were used to determine
significant differences across groups.
Results: The average age of schizophrenia caregivers was 45.3 years (SD = 15.8), and 59.6 % were female. After matching,
schizophrenia caregivers reported lower MCS (40.3 vs. 45.9), PCS (46.8 vs. 49.0), and health utilities (0.64 vs. 0.71) compared
with non-caregivers (all p< 0.001). Schizophrenia caregivers were more likely to experience sleep difficulties (42.7 % vs.
28.5 %), insomnia (32.4 % vs. 18.5 %), pain (39.7 % vs. 30.4 %), headaches (48.0 % vs. 42.0 %), heartburn (31.7 % vs. 22.9 %),
anxiety (37.9 % vs. 23.6 %), and depression (29.4 % vs. 19.4 %) than non-caregivers. Comparing schizophrenia caregivers
and other caregivers, schizophrenia caregivers reported lower MCS (40.3 vs. 42.7, p < 0.001), and health utilities (0.64 vs.
0.67, p < 0.001). Schizophrenia caregivers were more likely to experience sleep difficulties, insomnia, pain, and anxiety than
other caregivers. Almost 60 % of schizophrenia caregivers agree/strongly agree that caring for the patient is important to
them, but only 31.9 % agree/strongly agree that they have the financial resources to provide adequate care.
Conclusions: Schizophrenia caregivers reported worse HRQoL than non-caregivers and caregivers of other conditions.
Providing care for an adult relative with schizophrenia is important to caregivers, but caregivers need more resources to
provide adequate care. Providing informal schizophrenia caregivers with support services to help better manage patients
may improve their health status.
Keywords: Caregivers, Schizophrenia, Health-Related Quality of Life, Comorbidities, Health Utilities, Depression
* Correspondence: shaloo.gupta@kantarhealth.com
1Health Outcomes Practice, Kantar Health, 1 Independence Way, Suite 220,
Princeton, NJ 08540, USA
Full list of author information is available at the end of the article
© 2015 Gupta et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Gupta et al. BMC Psychiatry    
DOI 10.1186/s12888-015-0547-1
Background
Schizophrenia is a mental disorder that affects the pa-
tient’s ability to engage in day-to-day activities, which
increases the patients’ reliance on caregivers to assist
them. Objective caregiving burden involves the effects
on the household such as assisting patients in daily
tasks, which may include disrupted caregiver behavior
and daily routine, among others [1, 2]. Subjective care-
giving burden involves how caregivers perceive the bur-
den of care, which may include shame, embarrassment,
feelings of guilt, or self-blame, among others. Together,
these have consequences on the physical, psychological,
economic, and emotional well-being of schizophrenia
caregivers [1, 3–6].
For schizophrenia caregivers, burden is intensified by
the patient’s severity of symptoms, duration of illness,
number of needs, disability extent, decreased social inter-
ests, being male, and being older [1–3, 7, 8]. In particular,
schizophrenia with prominent positive or negative symp-
toms has been associated with lower functionality, health-
related quality of life (HRQoL), and lost work days among
caregivers, with greatest caregiver burden among patients
with the highest symptomatology [9]. While no previous
research, to the authors’ knowledge, have assessed whether
pharmacological interventions which helps improve pa-
tients’ disease control are directly associated with de-
creased caregiver burden in schizophrenia, high-quality
meta-analyses have shown that pharmacological inter-
ventions may have modest efficacy in mitigating burden
and distress among caregivers. Indeed, many studies have
shown improvements in caregiving burden associated
symptoms, even when caregiver responsibilities were not
alleviated [10].
It has been found that certain domains of caregiving
burden, such as tension and stress, are associated with
maladaptive coping mechanisms and increased risk of
psychological morbidity in schizophrenia caregivers [11].
Yet, the “burden of care” is a complex construct often
defined by the impact on caregivers, and often criticized
for focusing only on the negative aspects of caregiving
[1]. Notably, other domains of caregiving, such as satis-
faction and meaning derived from caregiving, have been
found to be negatively associated with subjective burden,
and positively associated with HRQoL, among schizo-
phrenia caregivers, elucidating the positive effects of
caregiving. Indeed, the literature does suggest caregivers
experience gains from their caregiving experience by be-
coming more sensitive to persons with disabilities, find-
ing clarity in their priorities in life, and a greater sense
of inner strength. Moreover, they experience positive
personal experiences and positive aspects in their rela-
tionships with the patients. In turn, the positive aspects
of caregiving have been associated with higher HRQoL
among caregivers [12, 13].
Indeed, the World Health Organization (WHO)
European Mental Health Plan guidelines advise that “The
coping capacity and skills of families should be assessed
regularly, and measures taken to ensure that families
benefit from the necessary support, education and the
provision of resources…” and that it is up to the public
health system of each country to help “identify and pro-
vide resources to support families that look after loved
ones requiring long-term care, including education, relief
services and adequate benefits” [14].
While much research has been done to characterize the
burden of providing care to schizophrenia patients, only a
handful of studies have directly compared HRQoL and co-
morbidities for schizophrenia caregivers to non-caregiver
controls and other caregivers. Moreover, previous studies
have utilized non-representative and relatively small sam-
ples [4, 6]. To the authors’ knowledge, only two studies
have directly compared caregiver burden in schizophrenia
and caregivers of other conditions in Europe (France and
Cyprus) [15, 16]. Although caring for both schizophrenia
and patients with other conditions impacts the well-being
of caregivers, differences in the onset of disease and dis-
ease symptoms may suggest that these diseases will affect
different aspects of caregiver burden.
There were three primary purposes to the present study.
First, given that the evidence on the health status of care-
givers of adults with schizophrenia in the existing literature
is limited in Europe, informal schizophrenia caregivers and
non-caregiver controls across 5EU were compared on
measures of HRQoL, and comorbidities experienced in the
past 12 months. Second, informal schizophrenia caregivers
were compared with adult caregivers of other conditions
(e.g., Alzheimer’s disease, cancer, stroke, etc.) on these
same measures. Third, schizophrenia caregivers’ subjective
assessment of the caregiving experience, both as a positive
experience and as a burden, was characterized. This study
uses the National Health and Wellness Survey (NHWS),
which provides a large, nationally representative sample.
Method
Sample and procedure
The current study includes data from the 5EU NHWS.
The NHWS is an annual, cross-sectional, self-administered
questionnaire from a sample of adults aged 18 or older
(www.kantarhealth.com). The following study included the
following five EU countries: France, Germany, Italy, Spain,
and United Kingdom (UK). The NHWS is intended to rep-
resent the entire adult population of that country by
employing a stratified random sampling framework. The
demographic distributions of each country are obtained
from the International Database from the United States
Bureau of the Census; potential respondents are selected
in such a way as to mirror these characteristics. Specific-
ally, the age and gender distributions are matched in the
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5EU countries. Potential respondents are recruited from
various online panels by using opt-in emails, co-registration
with panel partners, e-newsletter campaigns, and online
banner placements. All panelists must explicitly agree to be
a panel member, register with the panel through a unique
email address, and complete an in-depth demographic
registration profile. In all countries, the primary method of
data collection is through the Internet. However to ensure
a representative sample in France, Germany, Italy, and
Spain, particularly in the older population (>65), online re-
cruitment was supported by computer assisted web inter-
views (CAWIs), where respondents were recruited by
telephone and had the choice to complete the interview on
the phone while the interviewer entered the responses on-
line, or were e-mailed a link to the survey to complete on
their own. The NHWS was approved by Essex Institutional
Review Board (Lebanon, NJ, USA), and all respondents
provided informed consent by selecting “I agree to partici-
pate” to the question “Do you voluntarily agree to partici-
pate in this study?”. Participants who completed the
NHWS received compensation in the form of points, which
could be redeemed for small prizes or entered into a draw-
ing. All information was self-reported by respondents.
This study included combined data from the 2010, 2011
and 2013 5EU NHWS datasets (the 5EU NHWS was not
fielded in 2012). The current study pooled together
multiple years of data to increase the sample size of re-
spondents providing care for an adult relative with schizo-
phrenia. It is possible for a respondent to complete more
than one survey over a several year period; only the most
recent data for a given respondent was kept in these in-
stances. All NHWS respondents were asked, “Are you cur-
rently caring for an adult relative with any of the following
conditions?”, several response conditions were listed (e.g.,
schizophrenia, Alzheimer’s disease, stroke, multiple scler-
osis, epilepsy, and cancer). Data were analyzed for respon-
dents who self-reported being a caregiver for an adult
relative with schizophrenia and were compared to two
groups i) respondents not providing care for an adult rela-
tive with any condition (non-caregivers) and ii) respon-
dents who self-reported providing care for an adult with a
condition other than schizophrenia (e.g., Alzheimer’s dis-
ease, cancer, stroke, etc.) (other caregivers).
Demographics and health characteristics
The following demographic and health characteristics were
assessed: country, age (continuous), gender (male or fe-
male), marital status (married/living with partner vs. single/
divorced/separated/widowed), education (college/university
degree vs. less than college/university degree), household in-
come [low (<€20,000/<£20,000), high (≥€50,000/≥£40,000),
decline to answer vs. medium (€20,000 to <50,000/£20,000
to < £40,000)], employment status (currently employed
(full-time, part-time or self-employed) vs. not currently
employed), body mass index (BMI; overweight, obese, or
decline to answer vs. underweight/normal weight) was cal-
culated using height and weight information, smoking sta-
tus (currently smoke, former smoker vs. never smoked),
alcohol use (currently drink alcohol vs. do not drink alco-
hol), exercised vigorously for at least 20 min in the past
30 days (exercised at least once vs. not), and an adjusted
Charlson comorbidity index (CCI) [17]. The CCI weights
the presence of the following self-reported conditions and
sums the result: HIV/AIDS, metastatic tumor, lymphoma,
leukemia, any tumor, moderate/severe renal disease, hemi-
plegia, diabetes, mild liver disease, ulcer disease, connect-
ive tissue disease, chronic pulmonary disease, dementia,
cerebrovascular disease, peripheral vascular disease, myo-
cardial infarction, congestive heart failure, and diabetes
with end organ damage. The original CCI predicts the
likelihood of mortality. In the current study the CCI pro-
vides an estimate of comorbidity burden and the greater
the total index score, the greater the comorbid burden on
the individual.
Dependent measures
HRQoL was assessed using the physical (PCS) and men-
tal component summary (MCS) scores from the Short
Form (SF)-12v2 (2010 NHWS) and SF-36v2 (2011 and
2013 NHWS), as well as the health utility measure (SF-
6D) [18–20]. As a standard for the SF-36v2, PCS, and
MCS scores are normed to the U.S. population (M = 50,
SD = 10), with higher scores indicating greater HRQoL
[8]. The health utility score is a preference-based single
index measure for health using general population
values, with higher scores indicating better health status.
A difference greater than 3 in either PCS or MCS was
regarded as a minimally important difference (MID) and
a difference greater than 0.041 on health utilities was
identified as a MID [21, 22].
Comorbidities were investigated through the presence
of insomnia, narcolepsy, sleep difficulties (no definition of
sleep difficulties was provide, sleep difficulties can overlap
with insomnia or narcolepsy with self-reported data), ex-
periencing pain (any kind), migraines, headaches, heart-
burn, anxiety, and depression with the self-reported
measure “have you experienced the following in the past
twelve months”. Symptoms of depression were also
assessed using the Patient Health Questionnaire-9 (PHQ-
9). The PHQ-9 is an instrument which incorporates the
DSM-IV (Diagnostic and Statistical Manual of Mental Dis-
orders, 4th Edition) depression diagnostic criteria which in
turn measures the frequency of depression symptoms with
each item scored on a 4-point response scale (not at all = 0
to nearly every day = 3) in the past two weeks [23]. The
level of depression severity was assessed according to the
following total scores: 0–4 =minimal, 5–9 =mild, 10–14
=moderate, 15–19 =moderately severe, 20–27 = severe.
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The PHQ-9 was only available for NHWS 2011 and 2013
5EU respondents (67.5 %). All respondents also self-
reported if they were using a prescription medication for
depression.
Reaction to caregiving
The Caregiver Reaction Assessment (CRA) is a 24-item
scale designed to measure the reactions of family mem-
bers to caring for elderly relatives with a variety of ill-
nesses and it consists of 5 subscales (i.e., daily schedule,
financial situation, relationships with others, physical
health, and self-esteem) [24, 25]. The CRA corresponds
to the theoretical constructs of the labor of caregiving by
measuring the impact of “taking care” related to managing
the environment, preparing for death, and knowing one’s
strengths. Responses are measured on a 5-point Likert-
type scale (strongly disagree to strongly agree). The
CRA was only available for caregivers from the 2013
NHWS (n = 157). All individual items were dichoto-
mized as agree/strongly agree vs. other.
Statistical analyses
To analyze demographic, health status, and comorbidity
differences between schizophrenia caregivers, and non-
caregiver controls, and between schizophrenia caregivers,
and other caregivers, bivariate analyses were performed.
Chi-square tests were used with categorical variables;
ANOVAs were used with continuous variables.
Covariates noted above (demographics and health char-
acteristics) were entered into a single logistic regression
model to predict providing care to an adult patient with
schizophrenia vs. not providing care. Another separate lo-
gistic regression model was run to predict providing care
to an adult patient with schizophrenia vs. those providing
care for adults with a condition other than schizophrenia.
Schizophrenia caregivers were matched to non-caregiver
and other caregiver respondents on the propensity score
using the “greedy” matching algorithm [26]. A 1:2 match-
ing ratio was implemented, each schizophrenia caregiver
was matched to two non-caregiver control respondents
and separately to two caregivers of other conditions. Post-
match, differences between these groups were re-examined
to confirm sufficient matching. Also, the matching was
constrained so that all matches were within each 5EU
country.
Differences on HRQoL, and self-reported comorbidities
were examined post-matching to quantify the burden of
schizophrenia caregiving as a function of humanistic out-
comes. Chi-square and ANOVA tests were used to test for
statistical differences across i) those providing care for an
adult relative with schizophrenia vs. those not providing
care for an adult relative and ii) those providing care for
an adult relative with schizophrenia vs. those providing
care for an adult relative with a condition other than
schizophrenia. Statistical significance was set at 2-tailed
p <0.05.
Results
A total of 398 schizophrenia caregivers, 158,989 non-
caregivers controls and 14,341 caregivers of other condi-
tions were identified via 5EU NHWS across 2010, 2011
and 2013. In this total sample of 173,728 adults across
the 5EU, 25.4 % were in France, 25.3 % in Germany,
25.6 % in the UK, 14.0 % in Italy, and 9.6 % in Spain.
Schizophrenia caregivers vs. non-caregivers
The average age of schizophrenia caregivers was
45.3 years (SD = 15.8 years), 59.6 % were female, 52.5 %
were currently employed, and 14.8 % reported an in-
come of ≥ €50,000/≥£40,000. Before matching, schizo-
phrenia caregivers compared with non-caregivers, were
more likely to be female (59.6 % vs. 51.4 %), less likely to
be married/living with partner (57.4 % vs. 62.8 %), re-
ported lower annual household income, were less likely
to be employed (52.5 % vs. 57.7 %), more likely to cur-
rently smoke (36.7 % vs. 26.1 %), and reported greater
comorbidity burden via the CCI, all p <0.05. No statisti-
cally significant differences on age, education level, BMI,
alcohol use, and exercise behaviors were found between
the two groups (see Table 1).
After propensity matching, schizophrenia caregivers
were more likely to report experiencing sleep difficulties
(42.7 % vs. 28.5 %), insomnia (32.4 % vs. 18.5 %), pain
(39.7 % vs. 30.4 %), headaches (48.0 % vs. 42.0 %), heart-
burn (31.7 % vs. 22.9 %), anxiety (37.9 % vs. 23.6 %), and
depression (29.4 % vs. 19.4 %) in the past 12 months than
non-caregivers, all p <0.05. Based on the PHQ-9, schizo-
phrenia caregivers reported greater severity of depressive
symptoms than non-caregivers (p <0.001). Schizophrenia
caregivers were also more likely to currently be using a
prescription medication to treat depression (17.6 % vs.
8.2 %, p <0.001) than non-caregiver controls. Schizophrenia
caregivers reported significantly lower MCS (40.3 vs.
45.9), PCS (46.8 vs. 49.0), and health utility (0.64 vs.
0.71), compared with non-caregivers (all p <0.001) (see
Table 2).
Schizophrenia vs. other caregivers
Before propensity matching, schizophrenia caregivers
compared with caregivers of other conditions, were
younger (45.3 vs. 49.1 years), less likely to be married/
living with a partner (57.4 % vs. 68.1 %), had lower an-
nual household income, were more likely to currently
smoke (36.7 % vs. 29.2 %), and reported greater comor-
bidity burden, all p <0.05. No statistically significant dif-
ferences on gender, education level, employment status,
BMI, alcohol use, and exercise behaviors were found be-
tween the two groups (see Table 3).
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Table 1 Demographic and health characteristic information for schizophrenia caregivers and non-caregiver controls
Total Non-caregiver Schizophrenia caregiver for adult relative P-value
(N = 159,387) (N = 158,989) (N = 398)
Age (years) 0.156
Mean ± SD 46.44 ± 15.86 46.44 ± 15.86 45.31 ± 15.77
Country <0.001
France (%) 40399 (25.35 %) 40326 (25.36 %) 73 (18.34 %)
Germany (%) 41176 (25.83 %) 41094 (25.85 %) 82 (20.60 %)
Italy (%) 21708 (13.62 %) 21639 (13.61 %) 69 (17.34 %)
Spain (%) 14936 (9.37 %) 14863 (9.35 %) 73 (18.34 %)
UK (%) 41168 (25.83 %) 41067 (25.83 %) 101 (25.38 %)
Gender 0.001
Female (%) 81915 (51.39 %) 81678 (51.37 %) 237 (59.55 %)
Male (%) 77472 (48.61 %) 77311 (48.63 %) 161 (40.45 %)
Marital status 0.029
Single (%) 59243 (37.17 %) 59074 (37.16 %) 169 (42.46 %)
Married/living with partner (%) 100144 (62.83 %) 99915 (62.84 %) 229 (57.54 %)
Education level 0.051
Less than college/university degree (%) 105151 (65.97 %) 104870 (65.96 %) 281 (70.60 %)
College/university degree (%) 54236 (34.03 %) 54119 (34.04 %) 117 (29.40 %)
Annual household income <0.001
<€20,000/<£20,000 (%) 44431 (27.88 %) 44272 (27.85 %) 159 (39.95 %)
€20,000 to < €50,000/£20,000 to < £40,000 (%) 67854 (42.57 %) 67693 (42.58 %) 161 (40.45 %)
≥€50,000/≥£40,000 (%) 25151 (15.78 %) 25092 (15.78 %) 59 (14.82 %)
Decline to answer (%) 21951 (13.77 %) 21932 (13.79 %) 19 (4.77 %)
Employment status 0.038
Not currently employed (%) 67516 (42.36 %) 67327 (42.35 %) 189 (47.49 %)
Employed (%) 91871 (57.64 %) 91662 (57.65 %) 209 (52.51 %)
Body mass index 0.996
Underweight (%) 4483 (2.81 %) 4472 (2.81 %) 11 (2.76 %)
Normal weight (%) 69560 (43.64 %) 69390 (43.64 %) 170 (42.71 %)
Overweight (%) 52470 (32.92 %) 52338 (32.92 %) 132 (33.17 %)
Obese (%) 28630 (17.96 %) 28556 (17.96 %) 74 (18.59 %)
Decline to provide weight (%) 4244 (2.66 %) 4233 (2.66 %) 11 (2.76 %)
Alcohol use 0.281
Do not drink alcohol (%) 34504 (21.65 %) 34409 (21.64 %) 95 (23.87 %)
Drink alcohol (%) 124883 (78.35 %) 124580 (78.36 %) 303 (76.13 %)
Smoking behavior <0.001
Non-smoker (%) 65277 (40.96 %) 65165 (40.99 %) 112 (28.14 %)
Former smoker (%) 52450 (32.91 %) 52310 (32.90 %) 140 (35.18 %)
Current smoker (%) 41660 (26.14 %) 41514 (26.11 %) 146 (36.68 %)
Exercise behavior 0.505
Do not exercise (%) 65460 (41.07 %) 65290 (41.07 %) 170 (42.71 %)
Exercise at least once a month (%) 93927 (58.93 %) 93699 (58.93 %) 228 (57.29 %)
Charlson comorbidity index <0.001
Mean ± SD 0.28 ± 0.77 0.28 ± 0.77 0.61 ± 1.26
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After completing the propensity matching, schizophre-
nia caregivers were more likely to report experiencing
sleep difficulties (42.7 % vs. 36.8 %), insomnia (32.4 % vs.
26.0 %), pain (39.7 % vs. 31.5 %), and anxiety (37.9 % vs.
29.8 %) than other caregivers, all p <0.05. Based on the
PHQ-9, schizophrenia caregivers reported greater severity
of depressive symptoms than other caregivers (p = 0.003).
Schizophrenia caregivers were also more likely to be cur-
rently taking a prescription medication to treat depression
(17.6 % vs. 11.4 %, p = 0.003), but only a marginal signifi-
cant differences was found on schizophrenia caregivers ex-
periencing depression in the past 12 months (p = 0.069)
compared with caregivers of other conditions. Comparing
schizophrenia caregivers and other caregivers, schizophre-
nia caregivers reported lower MCS (40.3 vs. 42.7, p <0.001),
and health utilities (0.64 vs. 0.67, p <0.001). No statistically
significant difference was found on PCS scores between
schizophrenia caregivers and other caregivers (see Table 4).
Schizophrenia caregivers: reaction to caregiving
Notably, when asked about their caregiving experience,
the top 7 items (in terms of frequency) were positive about
the experience. The majority of caregivers responded that
caring for the patient was important to them (59.2 %) and
that they wanted to care for the patient (50.3 %). A sub-
stantial proportion of caregivers responded that they were
healthy enough to care for the patient (47.8 %), feeling pri-
vileged to care for the patient (44.0 %), having enough
physical strength to care for the patient (43.3 %), enjoyed
caring for the patient (42.7 %), and that caring for the pa-
tient makes them feel good (39.5 %) (see Fig. 1).
However, a substantial proportion of caregivers indi-
cated that the caregiving experience was burdensome. In
particular, caregivers indicated that caregiving had dis-
rupted their schedules (36.3 %), that their health had be-
come worse since starting caregiving (36.3 %), feeling
tired all the time since starting care for the patient
(35.0 %), not visiting friends and family as much as be-
fore (32.5 %), having difficulty relaxing because of con-
stant disruptions (31.2 %), and having to stop in the
middle of work (20.4 %).
A substantial proportion of caregivers indicated inad-
equate support caring for the patient. In particular, care-
givers responded that they had financial difficulty with
Table 2 Post-matched health outcome differences for schizophrenia caregivers vs. non-caregiver controls
Total Non-caregiver Schizophrenia caregiver for adult relative P-value
(N = 1,194) (N = 796) (N = 398)
PHQ-9 scalea <0.001
Minimal (%) 386 (32.33 %) 307 (38.57 %) 79 (19.85 %)
Mild (%) 221 (18.51 %) 137 (17.21 %) 84 (21.11 %)
Moderate (%) 106 (8.88 %) 59 (7.41 %) 47 (11.81 %)
Moderately Severe (%) 56 (4.69 %) 30 (3.77 %) 26 (6.53 %)
Severe (%) 39 (3.27 %) 13 (1.63 %) 26 (6.53 %)
Currently using a prescription medication for depression (%) 135 (11.31 %) 65 (8.17 %) 70 (17.59 %) <0.001
Comorbidities experienced in the past 12 months
Narcolepsy (%) 10 (0.84 %) 4 (0.50 %) 6 (1.51 %) 0.072
Insomnia (%) 276 (23.12 %) 147 (18.47 %) 129 (32.41 %) <0.001
Sleep difficulties (%) 397 (33.25 %) 227 (28.52 %) 170 (42.71 %) <0.001
Pain (%) 400 (33.50 %) 242 (30.40 %) 158 (39.70 %) 0.001
Anxiety (%) 339 (28.39 %) 188 (23.62 %) 151 (37.94 %) <0.001
Depression (%) 271 (22.70 %) 154 (19.35 %) 117 (29.40 %) <0.001
Heartburn (%) 308 (25.80 %) 182 (22.86 %) 126 (31.66 %) 0.001
Migraines (%) 284 (23.79 %) 178 (22.36 %) 106 (26.63 %) 0.102
Headaches (%) 525 (43.97 %) 334 (41.96 %) 191 (47.99 %) 0.048
Mental component summary <0.001
Mean ± SD 44.01 ± 11.15 45.88 ± 10.87 40.25 ± 10.75
Physical component summary <0.001
Mean ± SD 48.23 ± 9.98 48.96 ± 9.79 46.77 ± 10.20
Health utility <0.001
Mean ± SD 0.69 ± 0.13 0.71 ± 0.13 0.64 ± 0.12
aOnly available for 2011 and 2013 NHWS respondents (546 non-caregivers, 262 schizophrenia caregivers); Patient Health Questionnaire-9 = PHQ-9
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Table 3 Demographic and health characteristic information for schizophrenia caregivers and other caregivers
Total Caregiver for adult relative with a
condition other than schizophrenia
Schizophrenia caregiver for adult relative P-value
(N = 14,739) (N = 14,341) (N = 398)
Age (years) <0.001
Mean ± SD 49.04 ± 14.96 49.14 ± 14.93 45.31 ± 15.77
Country <0.001
France (%) 3887 (26.37 %) 3814 (26.60 %) 73 (18.34 %)
Germany (%) 2931 (19.89 %) 2849 (19.87 %) 82 (20.60 %)
Italy (%) 2681 (18.19 %) 2612 (18.21 %) 69 (17.34 %)
Spain (%) 1766 (11.98 %) 1693 (11.81 %) 73 (18.34 %)
UK (%) 3474 (23.57 %) 3373 (23.52 %) 101 (25.38 %)
Gender 0.467
Female (%) 8515 (57.77 %) 8278 (57.72 %) 237 (59.55 %)
Male (%) 6224 (42.23 %) 6063 (42.28 %) 161 (40.45 %)
Marital status <0.001
Single (%) 4745 (32.19 %) 4576 (31.91 %) 169 (42.46 %)
Married/living with partner (%) 9994 (67.81 %) 9765 (68.09 %) 229 (57.54 %)
Education level 0.121
Less than college/university degree (%) 9875 (67.00 %) 9594 (66.90 %) 281 (70.60 %)
College/university degree (%) 4864 (33.00 %) 4747 (33.10 %) 117 (29.40 %)
Annual household income <0.001
<€20,000/<£20,000 (%) 4299 (29.17 %) 4140 (28.87 %) 159 (39.95 %)
€20,000 to< €50,000/£20,000 to< £40,000 (%) 6489 (44.03 %) 6328 (44.13 %) 161 (40.45 %)
≥€50,000/≥£40,000 (%) 2200 (14.93 %) 2141 (14.93 %) 59 (14.82 %)
Decline to answer (%) 1751 (11.88 %) 1732 (12.08 %) 19 (4.77 %)
Employment status 0.692
Not currently employed (%) 6855 (46.51 %) 6666 (46.48 %) 189 (47.49 %)
Employed (%) 7884 (53.49 %) 7675 (53.52 %) 209 (52.51 %)
Body mass index 0.663
Underweight (%) 431 (2.92 %) 420 (2.93 %) 11 (2.76 %)
Normal weight (%) 5901 (40.04 %) 5731 (39.96 %) 170 (42.71 %)
Overweight (%) 4888 (33.16 %) 4756 (33.16 %) 132 (33.17 %)
Obese (%) 3153 (21.39 %) 3079 (21.47 %) 74 (18.59 %)
Decline to provide weight (%) 366 (2.48 %) 355 (2.48 %) 11 (2.76 %)
Alcohol use 0.424
Do not drink (%) 3276 (22.23 %) 3181 (22.18 %) 95 (23.87 %)
Drink alcohol (%) 11463 (77.77 %) 11160 (77.82 %) 303 (76.13 %)
Smoking behavior <0.001
Non-smoker (%) 5507 (37.36 %) 5395 (37.62 %) 112 (28.14 %)
Former smoker (%) 4893 (33.20 %) 4753 (33.14 %) 140 (35.18 %)
Current smoker (%) 4339 (29.44 %) 4193 (29.24 %) 146 (36.68 %)
Exercise behavior 0.613
Do not exercise (%) 6114 (41.48 %) 5944 (41.45 %) 170 (42.71 %)
Exercise at least once a month (%) 8625 (58.52 %) 8397 (58.55 %) 228 (57.29 %)
Charlson comorbidity index <0.001
Mean ± SD 0.44 ± 1.04 0.43 ± 1.04 0.61 ± 1.26
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the patient’s needs and services (34.4 %), that the care
had put a financial strain on their family (35.0 %), that it
is difficult to get help from their family (35.7 %), that
their family left them alone to take care of the patient
(28.0 %), their family “dumped” caring for the patient on
them (28.0 %), and that their family abandoned them
since starting care (21.0 %).
Discussion
In general, informal schizophrenia caregivers exhibited
poorer health-related outcomes than non-caregiver con-
trols. After matching schizophrenia caregivers with
non-caregivers with similar demographic and health char-
acteristics, a substantially greater proportion of caregivers
reported experiencing the following symptoms and condi-
tions: sleep difficulties, insomnia, pain, headaches, heart-
burn, anxiety, and depression, all p <0.05. Schizophrenia
caregivers also reported lower HRQoL and health utility
compared with non-caregiver controls, all p <0.05. Indeed,
the mean differences between schizophrenia caregivers
and non-caregiver controls were larger than the MID for
mental HRQoL and health utility.
Caregivers of schizophrenia patients and caregivers of
patients with conditions other than schizophrenia re-
ported similar poor health-related outcomes, although
some differences emerged. After matching schizophrenia
caregivers with caregivers of patients with conditions
other than schizophrenia but with similar demographic
and health characteristics, a substantially greater propor-
tion of schizophrenia caregivers reported the following
symptoms: sleep difficulties, insomnia, and anxiety, all p
<0.05. Moreover, a substantially greater proportion of
schizophrenia caregivers reported currently taking pre-
scription medication for depression and a greater level
of depression severity. Schizophrenia caregivers exhib-
ited significantly lower mean mental HRQoL and health
utility scores compared with caregivers of patients with
other conditions, though these differences did not ex-
ceed our pre-defined threshold of meaningfully import-
ant differences, all p <0.05.
Table 4 Post-matched health outcome differences for schizophrenia caregivers vs. other caregivers
Total Caregiver for adult relative with




(N = 1194) (N = 796) (N = 398)
PHQ-9 scalea 0.003
Minimal (%) 302 (25.29 %) 223 (28.02 %) 79 (19.85 %)
Mild (%) 223 (18.68 %) 139 (17.46 %) 84 (21.11 %)
Moderate (%) 151 (12.65 %) 104 (13.07 %) 47 (11.81 %)
Moderately Severe (%) 74 (6.20 %) 48 (6.03 %) 26 (6.53 %)
Severe (%) 52 (4.36 %) 26 (3.27 %) 26 (6.53 %)
Currently using a prescription medication
for depression (%)
161 (13.48 %) 91 (11.43 %) 70 (17.59 %) 0.003
Comorbidities experienced in the past
12 months
Narcolepsy (%) 11 (0.92 %) 5 (0.63 %) 6 (1.51 %) 0.134
Insomnia (%) 336 (28.14 %) 207 (26.01 %) 129 (32.41 %) 0.020
Sleep difficulties (%) 463 (38.78 %) 293 (36.81 %) 170 (42.71 %) 0.048
Pain (%) 409 (34.25 %) 251 (31.53 %) 158 (39.70 %) 0.005
Anxiety (%) 388 (32.50 %) 237 (29.77 %) 151 (37.94 %) 0.005
Depression (%) 312 (26.13 %) 195 (24.50 %) 117 (29.40 %) 0.069
Heartburn (%) 348 (29.15 %) 222 (27.89 %) 126 (31.66 %) 0.177
Migraines (%) 331 (27.72 %) 225 (28.27 %) 106 (26.63 %) 0.552
Headaches (%) 557 (46.65 %) 366 (45.98 %) 191 (47.99 %) 0.512
Mental component summary <0.001
Mean ± SD 41.85 ± 10.72 42.65 ± 10.62 40.25 ± 10.75
Physical component summary 0.315
Mean ± SD 47.19 ± 10.10 47.40 ± 10.05 46.77 ± 10.20
Health utility <0.001
Mean ± SD 0.66 ± 0.13 0.67 ± 0.13 0.64 ± 0.12
aOnly available for 2011 and 2013 NHWS respondents (540 other caregivers, 262 schizophrenia caregivers); Patient Health Questionnaire-9 = PHQ-9
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A prior review of published research of schizophrenia
caregiver burden found that, overall, this population expe-
riences deteriorated health, with stress problems, anxiety
and depression [27]. The current study corroborated these
findings, as informal schizophrenia caregivers reported
higher levels of these health issues relative to non-
caregivers and caregivers of conditions other than schizo-
phrenia. Zendijidjian et al. (2012) found that caregivers of
patients with affective disorders scored significantly lower
on all SF-36 domains than caregivers of schizophrenia
patients [15]. The current study, however, found signifi-
cant differences on the MCS, but not the PCS when com-
paring schizophrenia caregivers and caregivers of other
conditions. These differences could be due to the broader
criteria provided for caregivers of other conditions in the
current study. Papastavrou (2012), comparing schizophre-
nia, Alzheimer’s and cancer caregivers, on the other hand,
found that caregivers of cancer patients experienced the
highest levels of depression, while Alzheimer’s caregivers
experienced the highest levels of overall burden (p <0.001)
[16]. Unlike previous studies of schizophrenia caregivers,
the current study employed a representative sample of
schizophrenia caregivers, directly comparing HRQoL and
comorbidities for schizophrenia caregivers with non-
caregiver controls, and schizophrenia caregivers with other
caregivers. Because of this, making direct comparisons
with prior studies is limited. However, a prior study using
2010 and 2011 5EU NHWS reports higher MCS, PCS and
health utility scores for cancer caregivers than the current
studies schizophrenia caregivers [28], suggesting poten-
tially poorer HRQoL for schizophrenia caregivers than
caregivers of cancer patients. Therefore, overall, given pre-
vious literature and the current study results, the health
status of schizophrenia caregivers were found to be com-
parable if not worse than caregivers of other conditions.
The number of published studies elucidating the nega-
tive aspects of caregiving for patients with chronic illness
substantially outweighs the number of studies elucidating
the positive aspects [13]. Indeed, the current study is
unique in reporting the results of the CRA in a schizo-
phrenia caregiver population, corroborating prior re-

























0% 20% 40% 60% 80%
I have to stop in the middle of work
Since caring for the patient, I feel my family has abandoned me
I resent having to take care of the patient
I will never be able to do enough caregiving to repay the patient
Others have dumped caring for the patient onto me
My family (brothers, sisters, children) left me alone to care for the patient
The constant interruptions make it difficult to find time for relaxation
Financial resources are adequate to pay for things that are required for caregiving
I visit family and friends less since I have been caring for the patient
It's difficult to pay for the patient 's health needs and services
My activities are centered around care for the patient
Since caring for the patient, it seems like I'm tired all of the time
Caring for the patient has put a financial strain on the family
It is very difficult to get help from my family in taking care of the patient
My health has gotten worse since I've been caring for the patient
I have eliminated things from my schedule since caring for the patient
My family works together at caring for the patient
Caring for the patient makes me feel good
I enjoy caring for the patient
I have enough physical strength to care for the patient
I feel privileged to care for the patient
I am healthy enough to care for the patient
I really want to care for the patient
Caring for the patient is important to me
Fig. 1 Caregiver reactions assessment % agree/strong agree for schizophrenia caregivers (2013 only n = 157; 39.4 % of schizophrenia caregivers)
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burdensome, caregivers are able to have positive experi-
ences. The current study follows European region WHO
Mental Health Plan guidelines in that its aim, in part, was
to assess the ability of caregivers to cope with their caregiv-
ing experience [14, 17]. Notably, when asked about their
caregiving experience, the most frequent responses were
positive. The majority of caregivers indicated they wanted
to care for the patient and that caring for the patient was
important to them. However, a substantial proportion of
informal caregivers indicated that caregiving was an ob-
jective burden, in the form of disrupting their daily rou-
tines and work, and in limiting their social life. The
responses suggested that caregiving was also subjectively
burdensome as caregivers indicated their health had be-
come worse, feeling tired all the time, and having difficulty
relaxing because of constant interruptions since starting
care. A substantial proportion of caregivers indicated that
they lacked social and financial support, feeling that their
family had left them sole responsibility with caring for the
patient, and being isolated from the family and their
friends. Prior studies which utilized the CRA corroborated
these findings with caregiver responses being relatively low
for questions that indicated caregiver resentment and
high for questions regarding caregiver self-esteem, over
a variety of caregiver populations [29–33]. Also in
agreement with the current findings, the studies con-
sistently found that caregivers experience high levels of
financial burden, often lack social support from family
and formal sources, and that caregiving responsibilities
interfering with caregivers’ schedules is a prominent source
of burden. Direct comparisons between these studies,
however, are not feasible because of inconsistent sta-
tistical reporting. Moreover, the CRA lacks a composite
index summarizing total caregiving burden making com-
parisons of relative burden between caregiving po-
pulations difficult.
Together, these results suggest that while informal care-
givers want to care for their patients and feel privileged to
provide care, caregiving has an impact on caregivers both
objectively and subjectively. While the current study is
limited in being able to elucidate the causal direction
because of its cross-sectional nature, it is likely that the
observed differences in HRQoL and comorbidities are
caused by the burden of caregiving. Alternatively, it is pos-
sible that individuals with lower HRQoL and greater co-
morbidities self-select or are put into caregiving roles
more frequently. However, the symptoms and conditions
that were assessed (sleep difficulties, insomnia, pain, head-
aches, heartburn, anxiety, depression, etc.) are all asso-
ciated with chronic stress, and it seems more likely that
these would be caused by caregiving burden than being
predispositions for becoming a caregiver. Indeed, 36 % of
caregivers indicated that their health had become worse
since starting caregiving.
Further, providing care for an adult relative with
schizophrenia is important to caregivers, but the results
suggest caregivers may benefit from additional financial
and social support, and coping strategy, programs (as
described in the European region WHO Mental Health
Plan) as a substantial number of caregivers indicated in-
adequate resources to fulfill their care. As prior research
suggests that patient symptomatology has a meaningful
impact on the severity of caregiver burden [9]. Also, bet-
ter treatment options for patients with schizophrenia or
more-adequately treated patients would have the added
benefit of also alleviating caregiving burden [1]. Indeed,
prior research suggests that, on a population-wide scale,
this would amount to substantial humanistic and eco-
nomic benefit to society because of the “spill-over” effect
that chronic conditions have on patients’ families [1, 13].
Limitations
Although a representative sample of the 5EU, this sam-
ple may not have been representative of schizophrenia
caregivers, caregivers of conditions other than schizo-
phrenia, and non-caregiver controls. These analyses in-
cluded many covariates in the models, but other relevant
covariates may not have been included, such as the care-
giver’s type of employment and length of time providing
care for the patient with schizophrenia. Also, data on
caregiver relationship, patient symptoms, and patient
treatments were not collected, which could also have an
impact of the amount of caregiver burden. All responses
were self-reported and may reflect recall biases and
other forms of measurement error.
Because the majority of respondents were surveyed via
the internet, it is possible that the sample included youn-
ger caregivers, who are more likely to be educated on how
to use the internet, and older caregivers who are more ed-
ucated, and thus potentially healthier, than the caregiver
population at large. However, consideration was taken to
match caregivers to controls with similar sociodemo-
graphic characteristics, and therefore mean differences de-
rived from these analyses were less likely biased due to
oversampling healthier caregivers.
Although consideration have been given to explore alter-
native explanations for the observed mean differences in
health outcomes, it is possible that unmeasured variables
may have confounded the analyses. Moreover, schizophre-
nia diagnoses and caregiver status were not confirmed,
and it is possible that survey respondents may have mis-
classified themselves as caregivers of schizophrenia pa-
tients. The use of a cross-sectional design precludes the
ability to draw causal inferences from the data.
Conclusions
In conclusion, informal schizophrenia caregivers re-
ported worse HRQoL, health utilities, and experienced
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a greater number of comorbidities than non-caregivers
and caregivers of other conditions. However, providing
care for an adult relative with schizophrenia is important
to caregivers and they feel privileged to provide care, but
caregivers needed more resources to provide adequate
care. Providing informal schizophrenia caregivers with sup-
port services (e.g., financial support, social support, and
coping strategy programs) to help better manage patients
may improve their overall health status.
Competing interests
SG and GI are employees of Kantar Health, who were paid consultants to
Janssen in connection with the study design, analysis and interpretation of
data, writing of the article, and the publication submission decision. KVI is an
employee of Janssen, who funded and provided direction into the study
design, analysis and interpretation of data, writing of the article, and the
publication submission decision. KJ holds a consultancy role with Janssen,
and is an employee of the European Federation of Associations of Families
of People with Mental Illness, who endorsed the study, provided expert
insight into the study design, analysis and interpretation of data, reviewed
the writing of the article and provided insights on the publication
submission decision.
Authors’ contributions
SG, GI, KVI and KJ are responsible for the reported research, and have participated
in the concept and design, analysis and interpretation of data, drafting or revising
of the manuscript, and have approved the manuscript as submitted. SG, GI, KVI
and KJ have access to the study data supporting this publication. Although the
data are proprietary, the models and the methodology are not.
Acknowledgments
The authors wish to acknowledge the background research and editorial
assistance of Jan-Samuel Wagner, MPH, who is a paid consultant of Kantar Health.
Funding sources
This study was funded by Janssen.
Author details
1Health Outcomes Practice, Kantar Health, 1 Independence Way, Suite 220,
Princeton, NJ 08540, USA. 2Kantar Health, Epsom, Surrey, UK. 3European
Federation of Associations of Families of People with Mental Illness, Diestsevest
100, B-3000 Leuven, Belgium. 4Janssen-Cilag GmbH, Neuss, Germany.
Received: 9 March 2015 Accepted: 30 June 2015
References
1. Awad AG, Voruganti LN. The burden of schizophrenia on caregivers: a
review. Pharmacoeconomics. 2008;26(2):149–62.
2. Ochoa S, Vilaplana M, Haro JM, Villalta-Gil V, Martinez F, Negredo MC, et al.
Do needs, symptoms or disability of outpatients with schizophrenia influence
family burden? Soc Psychiatry Psychiatr Epidemiol. 2008;43(8):612–8.
3. Aranda-Reneo I, Oliva-Moreno J, Vilaplana-Prieto C, Hidalgo-Vega A,
Gonzalez-Dominguez A. Informal care of patients with schizophrenia.
J Ment Health Policy Econ. 2013;16(3):99–108.
4. Boyer L, Caqueo-Urizar A, Richieri R, Lancon C, Gutierrez-Maldonado J,
Auquier P. Quality of life among caregivers of patients with schizophrenia: a
cross-cultural comparison of Chilean and French families. BMC Fam Pract.
2012;13:42.
5. Fe Bravo-Ortiz M, Gutierrez-Casares JR, Rodriguez-Morales A, Garcia MA,
Hidalgo-Borrajo R. Influence of type of treatment on the well-being of
Spanish patients with schizophrenia and their caregivers. Int J Psychiatry
Clin Pract. 2011;15(4):286–95.
6. Papastavrou E, Charalambous A, Tsangari H, Karayiannis G. The cost of caring:
the relative with schizophrenia. Scand J Caring Sci. 2010;24(4):817–23.
7. Parabiaghi A, Lasalvia A, Bonetto C, Cristofalo D, Marrella G, Tansella M, et al.
Predictors of changes in caregiving burden in people with schizophrenia: a
3-year follow-up study in a community mental health service. Acta Psychiatr
Scand Suppl. 2007;437:66–76.
8. Grandon P, Jenaro C, Lemos S. Primary caregivers of schizophrenia outpatients:
burden and predictor variables. Psychiatry Res. 2008;158(3):335–43.
9. Rabinowitz J, Berardo CG, Bugarski-Kirola D, Marder S. Association of
prominent positive and prominent negative symptoms and functional
health, well-being, healthcare-related quality of life and family burden: a
CATIE analysis. Schizophr Res. 2013;150(2–3):339–42.
10. Adelman RD, Tmanova LL, Delgado D, Dion S, Lachs MS. Caregiver burden:
a clinical review. JAMA. 2014;311(10):1052–60.
11. Kate N, Grover S, Kulhara P, Nehra R. Relationship of caregiver burden with
coping strategies, social support, psychological morbidity, and quality of life
in the caregivers of schizophrenia. Asian J Psychiatry. 2013;6(5):380–8.
12. Kate N, Grover S, Kulhara P, Nehra R. Positive aspects of caregiving and its
correlates in caregivers of schizophrenia: a study from north India. East
Asian Arch Psychiatry. 2013;23(2):45–55.
13. Kulhara P, Kate N, Grover S, Nehra R. Positive aspects of caregiving in
schizophrenia: A review. World J Psychiatry. 2012;2(3):43–8.
14. WHO. European Region Mental Health Plan; 2011.
15. Zendjidjian X, Richieri R, Adida M, Limousin S, Gaubert N, Parola N, et al.
Quality of life among caregivers of individuals with affective disorders.
J Affect Disord. 2012;136(3):660–5.
16. Papastavrou E, Charalambous A, Tsangari H, Karayiannis G. The burdensome and
depressive experience of caring: what cancer, schizophrenia, and Alzheimer's
disease caregivers have in common. Cancer Nurs. 2012;35(3):187–94.
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying
prognostic comorbidity in longitudinal studies: development and validation.
J Chronic Dis. 1987;40(5):373–83.
18. Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I.
Conceptual framework and item selection. Med Care. 1992;30(6):473–83.
19. Ware Jr J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey:
construction of scales and preliminary tests of reliability and validity.
Med Care. 1996;34(3):220–33.
20. Brazier J, Roberts J, Deverill M. The estimation of a preference-based
measure of health from the SF-36. J Health Econ. 2002;21(2):271–92.
21. Maruish M. User’s manual for the SF-36v2 Health Survey. 2011.
22. Walters SJ, Brazier JE. Comparison of the minimally important difference for two
health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005;14(6):1523–32.
23. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression
severity measure. J Gen Intern Med. 2001;16(9):606–13.
24. Given CW, Given B, Stommel M, Collins C, King S, Franklin S. The caregiver
reaction assessment (CRA) for caregivers to persons with chronic physical
and mental impairments. Res Nurs Health. 1992;15(4):271–83.
25. Siefert ML, Williams AL, Dowd MF, Chappel-Aiken L, McCorkle R. The
caregiving experience in a racially diverse sample of cancer family
caregivers. Cancer Nurs. 2008;31(5):399–407.
26. Parsons LS. Reducing bias in a propensity score matched-pair sample using
greedy matching techniques. In: Proceedings of the Twenty-Sixth Annual
SAS Users Group Conference. Cary, NC: SAS Institute Inc; 2001. p. 214–26.
27. Caqueo-Urizar A, Gutierrez-Maldonado J, Miranda-Castillo C. Quality of life in
caregivers of patients with schizophrenia: a literature review. Health Qual
Life Outcomes. 2009;7:84.
28. Goren A, Gilloteau I, Lees M, DaCosta DM. Quantifying the burden of
informal caregiving for patients with cancer in Europe. Support Care Cancer.
2014;22(6):1637–46.
29. Brouwer WB, van Exel NJ, van de Berg B, Dinant HJ, Koopmanschap MA,
van den Bos GA. Burden of caregiving: evidence of objective burden,
subjective burden, and quality of life impacts on informal caregivers of
patients with rheumatoid arthritis. Arthritis Rheum. 2004;51(4):570–7.
30. Sautter JM, Tulsky JA, Johnson KS, Olsen MK, Burton-Chase AM,
Hoff Lindquist J, et al. Caregiver experience during advanced chronic
illness and last year of life. J Am Geriatr Soc. 2014;62(6):1082–90.
31. Utne I, Miaskowski C, Paul SM, Rustoen T. Association between hope and
burden reported by family caregivers of patients with advanced cancer.
Support Care Cancer. 2013;21(9):2527–35.
32. Coleman CI, Coleman SM, Vanderpoel J, Nelson W, Colby JA, Scholle JM,
et al. Factors associated with 'caregiver burden' for atrial fibrillation patients.
Int J Clin Pract. 2012;66(10):984–90.
33. Aggar C, Ronaldson S, Cameron ID. Self-esteem in carers of frail older
people: resentment predicts anxiety and depression. Aging Ment Health.
2011;15(6):671–8.
Gupta et al. BMC Psychiatry    Page 11 of 11
